PI
SPPI

Putnam Investments’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Putnam Investments’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-316,665
Closed -$2.66M – 1532
2013
Q3 		$2.66M Sell
316,665
-9,390
-3% -$76K 0.01% 968
2013
Q2 		$2.43M Buy
+326,055
New +$2.5M 0.01% 982

Other funds holding SPPI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Putnam Investments's SPPI Position: Q4 2013 in Review

Putnam Investments sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2013, closing a stake of 316,665 shares — an estimated $2.66M sold.

Putnam Investments first reported a position in SPPI in Q2 2013 and held it in 2 quarters. The position peaked at $2.66M in Q3 2013. 115 funds tracked by Wall St. Rank hold SPPI as of Q4 2013.

  • Putnam Investments reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Putnam Investments sold 316,665 Spectrum Pharmaceuticals Inc shares in Q4 2013, an estimated $2.66M.
  • Putnam Investments first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Putnam Investments's Spectrum Pharmaceuticals Inc position peaked at $2.66M in Q3 2013.
  • 115 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2013.

Based on Putnam Investments's 13F filing for Q4 2013, filed 13 Feb 2014.